Off-Label Prescription of COVID-19 Vaccines in Children: Clinical, Ethical, and Legal Issues

Pediatrics 2021:e2021054578 (2021)
  Copy   BIBTEX

Abstract

We argue that the universal recommendations against “off-label” pediatric use of approved COVID-19 issued by the FDA, CDC, and AAP are overbroad. Especially for higher-risk children, vaccination can be ethically justified even before FDA authorization or approval – and similar reasoning is relevant for even younger patients. Legal risks can also be managed, although the FDA, CDC, and Department of Health and Human Services (HHS) should move quickly to provide clarity.

Links

PhilArchive

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Ethical considerations for epidemic vaccine trials.Joshua Teperowski Monrad - 2020 - Journal of Medical Ethics 46 (7):465-469.
Ethical allocation of future COVID-19 vaccines.Rohit Gupta & Stephanie R. Morain - 2021 - Journal of Medical Ethics 47 (3):137-141.
Politicizing COVID-19 Vaccines in the Press: A Critical Discourse Analysis.Ali Haif Abbas - 2022 - International Journal for the Semiotics of Law - Revue Internationale de Sémiotique Juridique 35 (3):1167-1185.
Challenge Trials: What Are the Ethical Problems?Daniel M. Hausman - 2021 - Journal of Medicine and Philosophy 46 (1):137-145.

Analytics

Added to PP
2022-01-24

Downloads
225 (#86,655)

6 months
72 (#60,683)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Govind Persad
University of Denver

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references